1/16/2019 8:30:32 AM
Viveve Medical Reports $18.5 Mln In Preliminary 2018 Revenue
1/3/2019 8:28:40 AM
Viveve Medical Completes Enrollment In LIBERATE-International Trial
12/6/2018 4:12:45 PM
Viveve Announces Proposed Public Offering Of Shares Of Common Stock
9/13/2018 8:29:04 AM
Viveve Medical Adds Steve Basta And Karen Zaderej To Board
8/7/2018 8:29:02 AM
Viveve Announces FDA Approval To Continue VIVEVE II Clinical Study
7/10/2018 8:29:03 AM
Viveve Medical Reiterates 2018 Revenue Guidance Of $22 Mln -$24 Mln
7/3/2018 8:28:26 AM
Viveve Submits VIVEVE II Clinical Study 30-Day Patient Safety Data To FDA
6/4/2018 8:29:59 AM
Viveve Announces Settlement Of Patent Infringement Litigation With Thermi